Abbott diet drug study renews calls for U.S. ban (Reuters)

Reuters - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.

URL: http://us.rd.yahoo.com/dailynews/rss/weightloss/*http://news.yahoo.com/s/nm/20100902/hl_nm/us_abbott_ban